強迫性障害治療のグローバル臨床試験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Obsessive-Compulsive Disorder 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Obsessive-Compulsive Disorder 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Obsessive-Compulsive Disorder Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
H. Lundbeck A/S 36
Clinical Trial Overview of H. Lundbeck A/S 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Meiji Seika Pharma Co., Ltd. 39
Clinical Trial Overview of Meiji Seika Pharma Co., Ltd. 39
GlaxoSmithKline plc 40
Clinical Trial Overview of GlaxoSmithKline plc 40
Abbott Laboratories 41
Clinical Trial Overview of Abbott Laboratories 41
Clinical Trial Overview of Top Institutes / Government 42
National Institute of Mental Health 42
Clinical Trial Overview of National Institute of Mental Health 42
University of South Florida 43
Clinical Trial Overview of University of South Florida 43
Massachusetts General Hospital 44
Clinical Trial Overview of Massachusetts General Hospital 44
The Sheba Medical Center 45
Clinical Trial Overview of The Sheba Medical Center 45
New York State Psychiatric Institute 46
Clinical Trial Overview of New York State Psychiatric Institute 46
University of California, Los Angeles 47
Clinical Trial Overview of University of California, Los Angeles 47
University of Sao Paulo 48
Clinical Trial Overview of University of Sao Paulo 48
Tehran University of Medical Sciences 49
Clinical Trial Overview of Tehran University of Medical Sciences 49
Duke University 50
Clinical Trial Overview of Duke University 50
University of Florida 51
Clinical Trial Overview of University of Florida 51
Five Key Clinical Profiles 52
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 79


【レポート販売概要】

■ タイトル:強迫性障害治療のグローバル臨床試験動向(2014年下半期)
■ 英文:Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月28日
■ 調査会社:GlobalData
■ 商品コード:GDHC2255CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。